vs
APOGEE ENTERPRISES, INC.(APOG)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
APOGEE ENTERPRISES, INC.的季度营收约是REPLIGEN CORP的1.8倍($351.4M vs $197.9M),REPLIGEN CORP净利率更高(6.7% vs 4.7%,领先2.0%),REPLIGEN CORP同比增速更快(13.6% vs 1.6%),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 2.9%)
Apogee Enterprises是一家美国音频设备制造商,主营音频接口、模数与数模转换器、USB及iOS麦克风,同时还开发音频制作相关软件,产品广泛服务于专业录音、音乐创作等音频领域,在全球音频行业拥有较高的认可度。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
APOG vs RGEN — 直观对比
营收规模更大
APOG
是对方的1.8倍
$197.9M
营收增速更快
RGEN
高出12.0%
1.6%
净利率更高
RGEN
高出2.0%
4.7%
两年增速更快
RGEN
近两年复合增速
2.9%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $351.4M | $197.9M |
| 净利润 | $16.6M | $13.3M |
| 毛利率 | 22.4% | 52.5% |
| 营业利润率 | 7.3% | 9.0% |
| 净利率 | 4.7% | 6.7% |
| 营收同比 | 1.6% | 13.6% |
| 净利润同比 | 568.8% | 143.9% |
| 每股收益(稀释后) | $0.78 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APOG
RGEN
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $197.9M | ||
| Q3 25 | $358.2M | $188.8M | ||
| Q2 25 | $346.6M | $182.4M | ||
| Q1 25 | $345.7M | $169.2M | ||
| Q4 24 | $341.3M | $174.1M | ||
| Q3 24 | $342.4M | $154.9M | ||
| Q2 24 | $331.5M | $154.1M |
净利润
APOG
RGEN
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $13.3M | ||
| Q3 25 | $23.6M | $14.9M | ||
| Q2 25 | $-2.7M | $14.9M | ||
| Q1 25 | $2.5M | $5.8M | ||
| Q4 24 | $21.0M | $-30.3M | ||
| Q3 24 | $30.6M | $-654.0K | ||
| Q2 24 | $31.0M | $3.3M |
毛利率
APOG
RGEN
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | 52.5% | ||
| Q3 25 | 23.1% | 53.2% | ||
| Q2 25 | 21.7% | 50.0% | ||
| Q1 25 | 21.6% | 53.6% | ||
| Q4 24 | 26.1% | 26.1% | ||
| Q3 24 | 28.4% | 50.0% | ||
| Q2 24 | 29.8% | 49.8% |
营业利润率
APOG
RGEN
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | 9.0% | ||
| Q3 25 | 7.5% | 8.9% | ||
| Q2 25 | 2.0% | 7.6% | ||
| Q1 25 | 1.8% | 3.9% | ||
| Q4 24 | 8.4% | -17.7% | ||
| Q3 24 | 12.3% | -5.1% | ||
| Q2 24 | 12.5% | 1.0% |
净利率
APOG
RGEN
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | 6.7% | ||
| Q3 25 | 6.6% | 7.9% | ||
| Q2 25 | -0.8% | 8.2% | ||
| Q1 25 | 0.7% | 3.4% | ||
| Q4 24 | 6.1% | -17.4% | ||
| Q3 24 | 8.9% | -0.4% | ||
| Q2 24 | 9.4% | 2.2% |
每股收益(稀释后)
APOG
RGEN
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $0.24 | ||
| Q3 25 | $1.10 | $0.26 | ||
| Q2 25 | $-0.13 | $0.26 | ||
| Q1 25 | $0.12 | $0.10 | ||
| Q4 24 | $0.96 | $-0.55 | ||
| Q3 24 | $1.40 | $-0.01 | ||
| Q2 24 | $1.41 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $767.6M |
| 总债务越低越好 | $232.3M | $542.2M |
| 股东权益账面价值 | $511.8M | $2.1B |
| 总资产 | $1.1B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
APOG
RGEN
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $767.6M | ||
| Q3 25 | $39.5M | $748.7M | ||
| Q2 25 | $32.8M | $708.9M | ||
| Q1 25 | $41.4M | $697.2M | ||
| Q4 24 | $43.9M | $757.4M | ||
| Q3 24 | $51.0M | $784.0M | ||
| Q2 24 | $30.4M | $809.1M |
总债务
APOG
RGEN
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
APOG
RGEN
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $2.1B | ||
| Q3 25 | $500.2M | $2.1B | ||
| Q2 25 | $481.8M | $2.1B | ||
| Q1 25 | $487.9M | $2.0B | ||
| Q4 24 | $522.1M | $2.0B | ||
| Q3 24 | $506.4M | $2.0B | ||
| Q2 24 | $480.0M | $2.0B |
总资产
APOG
RGEN
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.2B | $2.9B | ||
| Q4 24 | $1.2B | $2.8B | ||
| Q3 24 | $917.1M | $2.8B | ||
| Q2 24 | $889.0M | $2.9B |
负债/权益比
APOG
RGEN
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $122.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | 7.8% | 4.1% |
| 现金转化率经营现金流/净利润 | 7.37× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势,按日历期对齐
经营现金流
APOG
RGEN
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $25.7M | ||
| Q3 25 | $57.1M | $48.1M | ||
| Q2 25 | $-19.8M | $28.6M | ||
| Q1 25 | $30.0M | $15.0M | ||
| Q4 24 | $31.0M | $39.2M | ||
| Q3 24 | $58.7M | $49.3M | ||
| Q2 24 | $5.5M | $42.2M |
自由现金流
APOG
RGEN
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $17.6M | ||
| Q3 25 | $52.4M | $43.4M | ||
| Q2 25 | $-26.9M | $21.5M | ||
| Q1 25 | $19.1M | $11.4M | ||
| Q4 24 | $22.0M | $33.6M | ||
| Q3 24 | $50.2M | $42.3M | ||
| Q2 24 | $-1.8M | $37.4M |
自由现金流率
APOG
RGEN
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 8.9% | ||
| Q3 25 | 14.6% | 23.0% | ||
| Q2 25 | -7.8% | 11.8% | ||
| Q1 25 | 5.5% | 6.8% | ||
| Q4 24 | 6.4% | 19.3% | ||
| Q3 24 | 14.7% | 27.3% | ||
| Q2 24 | -0.5% | 24.3% |
资本支出强度
APOG
RGEN
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 4.1% | ||
| Q3 25 | 1.3% | 2.5% | ||
| Q2 25 | 2.1% | 3.9% | ||
| Q1 25 | 3.2% | 2.1% | ||
| Q4 24 | 2.6% | 3.2% | ||
| Q3 24 | 2.5% | 4.5% | ||
| Q2 24 | 2.2% | 3.1% |
现金转化率
APOG
RGEN
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | 1.93× | ||
| Q3 25 | 2.41× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 12.08× | 2.57× | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | — | ||
| Q2 24 | 0.18× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
RGEN
暂无分部数据